VANCOUVER, June 11, 2014 /CNW/ - CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF), a North American medical company focussed on
providing physicians with innovative products for the treatment of
gastrointestinal diseases, today announced that Edward Wright, CRH's
Chief Executive Officer, will present an update on the Company's
progress at the Bloom Burton & Co. Healthcare Investor Conference at
the Toronto Board of Trade on June 18, 2014 at 11:00 a.m. EDT in
CRH's corporate presentation will be available on the Company website at
http://investors.crhsystem.com following the presentation.
Bloom Burton's third annual healthcare investor conference features
Canada's premier publicly-traded and venture-backed private companies.
The event will attract Canadian, U.S. and European investors who are
interested in the latest developments in Canadian healthcare companies.
About CRH Medical Corporation:
CRH Medical Corporation is North American company focussed on providing
physicians with innovative products for the treatment of
gastrointestinal diseases. The Company's lead product, the CRH O'Regan
System, is a single use, disposable, hemorrhoid treatment that is safe
and highly effective in treating hemorrhoid grades I - IV. The O'Regan
System is rapidly emerging as the standard of care with
gastroenterologists who treat hemorrhoids. In addition to the product,
CRH Medical delivers clinical, marketing and operational support
directly to its partner physicians. CRH utilizes its web-based platform
to connect doctors with patients as well as educating its ever
increasing install base of physicians.
SOURCE: CRH Medical Corporation
For further information:
Edward Wright, Chief Executive Officer
CRH Medical Corporation
Adam Peeler, Media and Investor Relations
416.815.0700 x 225